Cefuroxime + Clavulanic Acid in pharma in Chhattisgarh

Cefuroxime + Clavulanic Acid in PCD pharma franchise in Chennai

Cefuroxime + Clavulanic Acid in top pharma company in Belagavi

Cefuroxime + Clavulanic Acid in pcd pharma supplier in Amritsar

Cefuroxime + Clavulanic Acid in phama franchise company in India
Cefuroxime + Clavulanic Acid in phama distributor in Jamshedpur

Home/Products /cefuroxime-500mg-clavulanic-acid-125mg-tablet

Cefuzrom CV Tablet

Composition : Cefuroxime (500mg) + Clavulanic Acid (125mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹703/-

Cefuzrom CV Tablet combines two potent antibiotics, cefuroxime and clavulanic acid, to provide a broad-spectrum antibacterial effect. Cefuroxime is a cephalosporin antibiotic effective against a wide range of gram-positive and gram-negative bacteria, making it a valuable treatment for various infections. Clavulanic acid, a beta-lactamase inhibitor, enhances the efficacy of cefuroxime by preventing certain bacteria from inactivating the antibiotic. This combination is particularly effective for treating respiratory tract infections, urinary tract infections, skin infections, and other bacterial infections where resistance may be a concern.

Patients may experience some side effects while taking Cefuzrom CV. Commonly reported adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Allergic reactions, though rare, may occur and can manifest as rashes, itching, or swelling. It is crucial for patients to monitor their health and consult a healthcare professional if they experience severe side effects or signs of an allergic reaction.

When taking Cefuzrom CV, it is essential to adhere to the prescribed dosage and complete the full course of treatment, even if symptoms improve before finishing the medication. This practice helps prevent antibiotic resistance and ensures the infection is fully resolved.

Read More

About the Product

Cefuzrom CV Tablet combines two potent antibiotics, cefuroxime and clavulanic acid, to provide a broad-spectrum antibacterial effect. Cefuroxime is a cephalosporin antibiotic effective against a wide range of gram-positive and gram-negative bacteria, making it a valuable treatment for various infections. Clavulanic acid, a beta-lactamase inhibitor, enhances the efficacy of cefuroxime by preventing certain bacteria from inactivating the antibiotic. This combination is particularly effective for treating respiratory tract infections, urinary tract infections, skin infections, and other bacterial infections where resistance may be a concern.

Patients may experience some side effects while taking Cefuzrom CV. Commonly reported adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Allergic reactions, though rare, may occur and can manifest as rashes, itching, or swelling. It is crucial for patients to monitor their health and consult a healthcare professional if they experience severe side effects or signs of an allergic reaction.

When taking Cefuzrom CV, it is essential to adhere to the prescribed dosage and complete the full course of treatment, even if symptoms improve before finishing the medication. This practice helps prevent antibiotic resistance and ensures the infection is fully resolved.

Possible side effects include gastrointestinal issues, allergic reactions, and superinfection.

Used for the treatment of bacterial infections such as respiratory, urinary tract, and skin infections.

Consult a healthcare professional before use, especially if you have a history of allergies or kidney problems.

Store in a cool, dry place away from direct sunlight and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation